Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The genetic landscape of histologically transformed marginal zone lymphomas.
Li A, Yi H, Deng S, Ruan M, Xu P, Huo Y, Lu H, Shen X, Ouyang B, Cai M, Xu H, Wang Z, Zhang L, Zhu L, Peng Q, Gu Y, Xie J, Wang Y, Dong L, Liu Z, Wang C. Li A, et al. Among authors: xu p, xu h. Cancer. 2024 Apr 15;130(8):1246-1256. doi: 10.1002/cncr.35072. Epub 2023 Nov 8. Cancer. 2024. PMID: 37941429
A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Xu PP, Xiong J, Cheng S, Zhao X, Wang CF, Cai G, Zhong HJ, Huang HY, Chen JY, Zhao WL. Xu PP, et al. EBioMedicine. 2017 Nov;25:41-49. doi: 10.1016/j.ebiom.2017.10.011. Epub 2017 Oct 12. EBioMedicine. 2017. PMID: 29056540 Free PMC article. Clinical Trial.
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
Xiong J, Cui BW, Wang N, Dai YT, Zhang H, Wang CF, Zhong HJ, Cheng S, Ou-Yang BS, Hu Y, Zhang X, Xu B, Qian WB, Tao R, Yan F, Hu JD, Hou M, Ma XJ, Wang X, Liu YH, Zhu ZM, Huang XB, Liu L, Wu CY, Huang L, Shen YF, Huang RB, Xu JY, Wang C, Wu DP, Yu L, Li JF, Xu PP, Wang L, Huang JY, Chen SJ, Zhao WL. Xiong J, et al. Cancer Cell. 2020 Mar 16;37(3):403-419.e6. doi: 10.1016/j.ccell.2020.02.005. Cancer Cell. 2020. PMID: 32183952 Free article.
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.
Cai MC, Cheng S, Wang X, Hu JD, Song YP, Huang YH, Yan ZX, Jiang YJ, Fang XS, Zheng XY, Dong LH, Ji MM, Wang L, Xu PP, Zhao WL. Cai MC, et al. Genome Med. 2020 Apr 30;12(1):41. doi: 10.1186/s13073-020-00739-0. Genome Med. 2020. PMID: 32349779 Free PMC article. Clinical Trial.
10,455 results
You have reached the last available page of results. Please see the User Guide for more information.